Indacaterol EfectIveness In COPD Patients With Tuberculosis History

Clinical trial NCT01778062 · COMPLETED

Trial details

NCT number: NCT01778062
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Patients With Moderate-to-severe COPD With Destroyed Lung by Tuberculosis

Start date: 2013-02-01
Primary completion: 2014-09-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.